Pathological complete response in breast cancer patients following neoadjuvant chemotherapy at a Comprehensive Cancer Center: The natural history of an elusive prognosticator

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 775-780

Science Publishers

Access to resources Recommend Favorite

Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer

By Fernández-Sánchez Mónica   Gamboa-Dominguez Armando   Uribe Norma   García-Ulloa Ana   Flores-Estrada Diana   Candelaria Myrna   Arrieta Oscar  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 171-183

Humana Press, Inc

Access to resources Recommend Favorite

Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer

By                

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 663-668

Spandidos Publications

Access to resources Recommend Favorite

Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer

By                            

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 83-89

Spandidos Publications

Access to resources Recommend Favorite

Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer

By Ramaswamy Bhuvaneswari   Povoski Steven   Rhoades Chris   Allen Joan   Hauger Marsha   Young Donn   Burak William   Farrar William   Yee Lisa   Kendra Kari   Somasundaram Sivagurunathan   Orlowski Robert   Shapiro Charles  

Breast Cancer Research and Treatment, Vol. 93, Iss. 1, 2005-09 ,pp. : 67-74

Springer Publishing Company

Access to resources Recommend Favorite